China Resources Medical Holdings Company Limited (CR Medical, 01515) has announced that its board of directors will convene on 24 March 2026.
Key agenda items include:
1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.
2. Deliberating on the recommendation of a final dividend, if any.
3. Addressing any additional corporate matters.
The announcement, dated 9 March 2026 and signed by Chairman Yu Hai, also lists the current board composition: four executive directors (Yu Hai, Zhang Chuang, Wang Yuexing, Wu Xinchun), one non-executive director (Ge Lu), and four independent non-executive directors (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze).
The forthcoming board meeting will determine the publication timetable for CR Medical’s FY 2025 results and any proposed dividend distribution.
Comments